OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

Rhea-AI Summary

OraSure Technologies, Inc. (OSUR) will hold its earnings conference call for Q4 2023 financial results and business updates on Feb. 27, 2024, at 5 p.m. ET. The webcast will be available on the company's investor relations page. Participants can register in advance for access.

BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certain business developments for 5 p.m. ET on Tuesday, Feb. 27, 2024.

A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.

To participate in the live conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.

https://register.vevent.com/register/BI02fb7bbb6778405db15374b4d472fd84

About OraSure Technologies, Inc. 
OraSure Technologies (the “Company”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. The Company improves access, quality, and value of healthcare with innovation in effortless tests, sample management solutions, and services. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass diagnostics, tools, and services. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Investor Contact:	Media Contact:
Jason Plagman	Amy Koch
VP, Investor Relations	Director, Corporate Communications
investorinfo@orasure.com	media@orasure.com

When is OraSure Technologies, Inc.'s earnings conference call for Q4 2023 scheduled?

OraSure Technologies, Inc.'s earnings conference call for Q4 2023 is scheduled for Feb. 27, 2024, at 5 p.m. ET.

Where can I access the webcast of the conference call?

The webcast of the conference call will be available on the investor relations page of OraSure's website.

How long will the webcast be available for after the conference call?

The webcast will be archived on OraSure's website shortly after the call and will be available for approximately 90 days.

How can I participate in the live conference call?

To participate in the live conference call, pre-register using the provided link and access details will be sent via email.